"Multiple Sclerosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
Descriptor ID |
D009103
|
MeSH Number(s) |
C10.114.375.500 C10.314.350.500 C20.111.258.250.500
|
Concept/Terms |
Multiple Sclerosis- Multiple Sclerosis
- Sclerosis, Multiple
- Sclerosis, Disseminated
- Disseminated Sclerosis
- MS (Multiple Sclerosis)
|
Below are MeSH descriptors whose meaning is more general than "Multiple Sclerosis".
Below are MeSH descriptors whose meaning is more specific than "Multiple Sclerosis".
This graph shows the total number of publications written about "Multiple Sclerosis" by people in this website by year, and whether "Multiple Sclerosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 3 | 2 | 5 |
1999 | 4 | 0 | 4 |
2000 | 4 | 3 | 7 |
2001 | 8 | 1 | 9 |
2002 | 6 | 0 | 6 |
2003 | 10 | 2 | 12 |
2004 | 10 | 1 | 11 |
2005 | 10 | 1 | 11 |
2006 | 2 | 1 | 3 |
2007 | 6 | 1 | 7 |
2008 | 6 | 0 | 6 |
2009 | 6 | 2 | 8 |
2010 | 6 | 0 | 6 |
2011 | 6 | 2 | 8 |
2012 | 7 | 1 | 8 |
2013 | 9 | 2 | 11 |
2014 | 10 | 0 | 10 |
2015 | 5 | 1 | 6 |
2016 | 6 | 0 | 6 |
2017 | 11 | 2 | 13 |
2018 | 5 | 2 | 7 |
2019 | 10 | 1 | 11 |
2020 | 14 | 3 | 17 |
2021 | 15 | 1 | 16 |
2022 | 15 | 0 | 15 |
2023 | 10 | 0 | 10 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multiple Sclerosis" by people in Profiles.
-
[Core data set for real world data in multiple sclerosis: customization for latin america from a global task force recommendation]. Rev Neurol. 2024 Apr 01; 78(7):185-197.
-
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. Mult Scler. 2024 Mar; 30(3):308-315.
-
Evaluating noninvasive brain stimulation to treat overactive bladder in individuals with multiple sclerosis: a randomized controlled trial?protocol. BMC Urol. 2024 Jan 25; 24(1):20.
-
Cross-vendor multiparametric mapping of the human brain using 3D-QALAS: A multicenter and multivendor study. Magn Reson Med. 2024 May; 91(5):1863-1875.
-
Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Mult Scler Relat Disord. 2024 Feb; 82:105351.
-
Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder Survey. Pediatr Neurol. 2024 Feb; 151:115-120.
-
Predicting multiple sclerosis severity with multimodal deep neural networks. BMC Med Inform Decis Mak. 2023 11 09; 23(1):255.
-
Concurrence of inflammatory bowel disease with multiple sclerosis or Hodgkin lymphoma. Eur J Gastroenterol Hepatol. 2023 12 01; 35(12):1349-1353.
-
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2023 06; 43(6):473-484.
-
Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments. Pediatr Neurol. 2023 Aug; 145:125-131.